This is a non-core endpoint: only basic statistics are computed.
See its core counterpart CD2_IMMUNOPROLIFERATIVE_EXALLC for full statistics.
Malignant immunoproliferative diseases
CD2_IMMUNOPROLIFERATIVE
lymphoma: A malignant (clonal) proliferation of B- lymphocytes or T- lymphocytes which involves the lymph nodes, bone marrow and/or extranodal sites. This category includes Non-Hodgkin lymphomas and Hodgkin lymphomas.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
319 |
4. Check minimum number of eventsNone |
319 |
5. Include endpointsNone |
319 |
6. Filter based on genotype QC (FinnGen only) |
319 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- C81-C96
- Name in latin
- Morbi immunoproliferativi maligni
Similar endpoints
↥List of similar endpoints to
Malignant immunoproliferative diseases
based on the number of shared cases.
Similar with more cases:
- Malignant immunoproliferative diseases
- Primary_lymphoid and hematopoietic malignant neoplasms
- Primary_lymphoid and hematopoietic malignant neoplasms
- Malignant neoplasm
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 319 | 124 | 195 |
| Unadjusted period prevalence (%) | 0.07 | 0.04 | 0.09 |
| Median age at first event (years) | 67.83 | 65.99 | 69.00 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 293
- Matched controls
- 2930
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C88.0
ICD-10 Finland
Waldenström macroglobulinaemia
+∞
256.5
207
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
48.9
131.9
163
73
XW000
NOMESCO Finland
Bone marrow biopsy
41.3
111.3
142
65
9761/3-C42.0
ICD-O-3
Waldenstrom macroglobulinemia of blood
+∞
86.9
79
*
D47.2
ICD-10 Finland
Monoclonal gammopathy of undetermined significance (MGUS)
81.9
67.3
74
12
C88.9
ICD-10 Finland
Malignant immunoproliferative disease, unspecified
+∞
63.9
59
*
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
50.5
45.3
54
13
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
21.8
38.5
57
32
L03AA02
ATC
filgrastim; parenteral
16.2
34.0
56
42
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
6.2
31.3
96
213
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
26.3
29.7
41
18
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
18.6
29.7
46
29
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
9.3
29.3
64
85
M04AA01
ATC
allopurinol; systemic
4.9
26.6
104
298
9671/3-C42.1
ICD-O-3
Lymphoplasmacytic lymphoma of bone marrow
+∞
26.4
25
*
A04AA01
ATC
ondansetron; systemic, rectal
7.0
24.9
66
117
C88.7
ICD-10 Finland
Other malignant immunoproliferative diseases
+∞
23.2
22
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
21.2
23.2
34
18
WW500
NOMESCO Finland
Blood transfusion
9.7
23.0
48
58
1512
Kela drug reimbursment
Ibrutinib
236.9
21.9
22
*
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
37.0
21.5
27
8
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
54.4
21.5
25
5
R50.9
ICD-10 Finland
Fever, unspecified
4.7
20.9
80
217
390
Kela drug reimbursment
Ibrutinib
118.5
20.9
22
*
L01AA02
ATC
chlorambucil; oral
59.2
19.2
22
*
JN4BD
NOMESCO Finland
Extensive body CT
4.0
17.5
78
242
1XC02
NOMESCO Finland
NA
37.5
16.9
21
6
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
6.9
16.9
43
71
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
7.6
16.7
40
60
C83.01
ICD-10 Finland
Lymphoplasmacytic lymphoma
179.7
16.7
17
*
L03AA13
ATC
pegfilgrastim; parenteral
8.1
16.3
37
51
L01EL01
ATC
ibrutinib; oral
+∞
15.8
15
*
ZX120
NOMESCO Finland
Intravenous
4.4
15.7
62
170
H02AB06
ATC
prednisolone; systemic
2.7
14.9
173
1020
EP1AE
NOMESCO Finland
Neck ultrasound examination
5.8
14.5
42
82
J05AB11
ATC
valaciclovir; oral
3.8
14.0
64
200
J05AB01
ATC
aciclovir; systemic
3.2
13.9
87
345
C88.4
ICD-10 Finland
Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lyphoma]
+∞
13.6
13
*
N08.1*C88.0
ICD-10 Finland
Glomerular disorders in Waldenström's macroglobulinaemia
+∞
13.6
13
*
D64.9
ICD-10 Finland
Anaemia, unspecified
3.7
13.3
64
208
JN4AD
NOMESCO Finland
Body CT examination
4.1
13.0
53
149
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
12.5
12.0
21
18
L01XE27
ATC
[U] ibrutinib; oral
67.7
11.7
13
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.3
11.6
63
223
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.4
11.4
170
1083
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
13.6
10.8
18
14
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
13.6
10.8
18
14
9591/3-C42.1
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of bone marrow
+∞
10.5
10
*
L01AA01
ATC
cyclophosphamide; systemic
33.9
10.4
13
*
TPH04
NOMESCO Finland
Cathetrisation of vein
2.6
10.4
93
449
B03XA01
ATC
erythropoietin; parenteral
19.7
10.4
15
8
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
15.3
10.1
16
11
C83.1
ICD-10 Finland
Mantle cell lymphoma
17.5
10.0
15
9
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.1
9.8
38
102
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.4
9.7
108
582
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
15.7
9.6
15
10
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
31.1
9.5
12
*
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
7.1
9.3
22
33
NJ3DA
NOMESCO Finland
Long bones of extremities X-ray examination
37.9
9.1
11
*
D70.89
ICD-10 Finland
Neutropenic splenomegaly
19.3
9.0
13
7
C90.0
ICD-10 Finland
Multiple myeloma
11.2
8.9
16
15
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
51.5
8.7
10
*
JN6AD
NOMESCO Finland
CT of torso and neck
12.1
8.7
15
13
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
13.3
8.5
14
11
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
12.2
8.2
14
12
127
Kela drug reimbursment
Transplant complication
12.2
8.2
14
12
J01MA14
ATC
moxifloxacin; systemic
3.2
7.9
41
140
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.2
7.9
97
538
WW200
NOMESCO Finland
Immunization
6.2
7.8
20
34
A03FA01
ATC
metoclopramide; systemic, rectal
2.3
7.8
82
420
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
7.8
7.8
17
23
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
46.2
7.8
9
*
J01MA12
ATC
levofloxacin; systemic
2.3
7.7
76
381
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
12.3
7.6
13
11
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
10.4
7.6
14
14
H02AB02
ATC
dexamethasone; systemic
2.8
7.5
50
202
D47.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified
82.1
7.4
8
*
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
7.1
7.4
17
25
D70.82
ICD-10 Finland
Drug-induced neutropenia
7.1
7.4
17
25
B03XA02
ATC
darbepoetin alfa; parenteral
6.5
7.4
18
29
L03AA14
ATC
lipegfilgrastim; parenteral
6.9
7.2
17
26
C83.39
ICD-10 Finland
Diffuse non-Hodgkin's large cell lymphoma UNS
20.6
7.2
10
5
TAB00
NOMESCO Finland
Lumbar puncture
5.2
7.1
21
43
A41.9
ICD-10 Finland
Sepsis, unspecified
4.4
7.0
24
58
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
4.3
6.9
24
59
L04AA06
ATC
mycophenolic acid; systemic
11.3
6.9
12
11
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
17.2
6.8
10
6
WW300
NOMESCO Finland
Transfer of autologic stem cells
41.0
6.8
8
*
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
14.7
6.4
10
7
UJF32
NOMESCO Finland
Coloscopy
2.0
6.3
90
525
9680/3-C77.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph node, NOS
+∞
6.3
6
*
C88.3
ICD-10 Finland
Immunoproliferative small intestinal disease
+∞
6.3
6
*
9689/3-C42.2
ICD-O-3
Splenic marginal zone B-cell lymphoma of spleen
+∞
6.3
6
*
A02BC02
ATC
pantoprazole; systemic
1.9
6.2
196
1512
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.0
6.2
104
643
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3028026) IgM [Mass/volume] in Serum or Plasma
208
178
31.71
228.95
12.5
1.4
g/l
13.7
1.1
28.53
199
159
(3037756) Immunofixation for Serum or Plasma
154
67
43.50
227.43
2.1
1.5
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
160
97
32.09
206.04
7.4
3.1
ratio
8.2
2.8
—
7
9
(3034860) Kappa light chains.free [Mass/volume] in Serum
161
99
31.82
206.03
7.4
3.2
mg/l
110.8
129.6
0.11
135
81
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
161
99
31.82
206.03
7.4
3.3
mg/l
29.7
38.0
0.82
136
82
(40760888) Immunoglobulin light chains.free panel - Serum
140
68
35.91
196.85
7.0
3.8
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
203
217
23.98
193.45
11.1
2.0
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
231
348
21.44
173.48
10.1
4.3
u/l
226.5
244.9
1.24
224
328
(3045142) Bone marrow Pathology biopsy report
105
43
35.91
155.17
1.5
1.2
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
178
218
17.21
151.27
6.1
2.2
g/l
7.8
9.9
4.94
173
195
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
132
105
20.74
145.25
10.5
1.9
g/l
8.0
0.6
10.62
111
95
(3042111) Morphology [Interpretation] in Bone marrow Narrative
107
66
23.89
133.12
1.6
1.7
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
130
128
16.45
125.09
10.1
1.8
g/l
7.0
7.5
1.71
95
97
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
130
128
16.45
125.09
10.0
1.8
g/l
3.9
3.7
0.27
84
92
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
130
128
16.45
125.09
10.1
1.8
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
121
120
15.63
115.25
10.5
1.8
g/l
3.0
3.3
0.98
86
94
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
118
117
15.42
112.20
10.2
1.8
g/l
15.2
10.3
4.22
95
101
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
100
88
16.10
101.72
2.5
1.6
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
70
32
27.74
97.66
1.9
2.5
—
—
—
0
0
(21494434) Karyotype in Bone marrow
67
38
22.05
85.07
1.1
1.1
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
170
378
8.49
82.77
5.9
2.8
%
1.7
1.8
1.10
160
343
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
92
103
12.15
79.02
10.7
1.8
g/l
37.5
36.7
0.45
80
89
(3023520) Reticulocytes [#/volume] in Blood
142
282
8.27
76.08
5.4
2.8
e9/l
65.3
68.3
0.37
118
217
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
105
148
10.08
75.71
2.9
2.3
g/l
1.5
1.5
0.33
92
128
(46235355) HIV 1 and 2 tests - Meaningful Use set
139
278
8.09
73.72
1.9
1.6
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
126
232
8.32
71.98
2.0
1.5
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
99
146
9.38
68.34
1.5
1.5
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
121
229
7.90
66.92
2.0
1.5
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
43
14
35.34
66.59
1.4
1.4
—
—
—
0
0
(3024316) Viscosity of Plasma
61
0
+∞
65.96
2.9
0.0
mpas
1.9
—
—
46
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
45
20
26.03
62.66
1.6
1.2
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
62
56
13.50
60.72
7.6
8.1
iu/ml
928.9
154.6
—
8
11
(3007164) IgA [Mass/volume] in Serum or Plasma
163
462
6.17
58.44
4.0
1.3
g/l
1.3
2.7
11.57
144
272
(3017817) Protein [Mass] in Urine collected for unspecified duration
42
25
19.20
51.41
2.1
3.2
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
198
732
5.49
50.32
7.3
3.1
umol/l
1564.9
9335.3
2.50
189
625
(42870588) Differential panel, method unspecified - Blood
218
885
5.62
49.01
15.8
5.8
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
44
33
15.31
47.75
3.0
1.9
e9/l
1.3
1.3
0.04
27
16
(3018010) Neutrophils/100 leukocytes in Blood
251
1193
6.18
45.21
14.5
5.9
%
54.8
58.1
3.54
244
1120
(3001604) Monocytes [#/volume] in Blood
260
1275
6.62
45.04
14.8
5.8
e9/l
0.6
0.6
1.44
241
1099
(3013115) Eosinophils [#/volume] in Blood
264
1316
6.84
44.71
16.2
5.9
e9/l
0.2
0.2
1.70
249
1152
(3006315) Basophils [#/volume] in Blood
260
1281
6.57
44.60
14.8
5.8
e9/l
0.0
0.0
0.22
241
1112
(3019198) Lymphocytes [#/volume] in Blood
262
1302
6.67
44.40
14.9
5.9
e9/l
1.9
1.9
0.02
247
1146
(3017181) Myelocytes/100 leukocytes in Blood
98
225
5.84
42.84
7.5
4.2
%
0.8
0.9
0.12
62
82
(4035726)
101
240
5.69
42.46
2.0
1.4
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
128
383
4.91
40.76
12.3
6.0
mmol/l
1.1
1.0
0.51
122
352
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
35
23
16.97
40.58
1.7
2.1
%
13.0
12.9
—
7
12
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
31
19
17.96
37.12
2.0
1.6
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
31
19
17.96
37.12
2.0
1.6
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
269
1484
6.18
36.88
28.3
9.3
e9/l
3.4
4.2
12.04
250
1307
(3002179) Metamyelocytes/100 leukocytes in Blood
84
198
5.40
35.12
8.1
4.1
%
0.5
0.3
0.41
40
61
(3021440) Promyelocytes/100 leukocytes in Blood
86
208
5.29
34.89
8.0
4.4
%
0.0
0.1
1.58
55
74
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
256
1400
5.20
34.29
19.5
7.2
mmol/l
1.2
1.2
0.52
219
1181
(3024561) Albumin [Mass/volume] in Serum or Plasma
235
1224
4.49
33.17
10.3
4.8
g/l
33.2
35.1
4.61
230
1149
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
50
75
7.72
32.88
2.9
1.8
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
41
49
9.45
32.48
6.0
4.2
%
1.5
1.0
0.38
32
41
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
29
22
14.40
30.94
1.8
2.2
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
43
58
8.41
30.90
2.5
1.9
—
—
—
0
0
(3017704) Immunofixation for Urine
28
20
15.25
30.88
1.3
1.5
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
47
75
7.18
29.13
3.5
1.8
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
33
35
10.40
28.44
1.7
1.1
—
—
—
0
0
(3018418) pH of Serum or Plasma
182
877
3.50
26.95
13.8
4.3
ph
7.4
7.4
0.49
44
160
(3025159) Blasts/100 leukocytes in Blood
73
195
4.56
25.72
7.9
4.5
%
0.0
0.1
0.44
43
65
(3012095) Magnesium [Moles/volume] in Serum or Plasma
123
488
3.47
24.46
8.8
3.7
mmol/l
0.8
0.8
0.60
118
460
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
155
717
3.26
23.80
2.8
2.1
mg/l
3.2
3.1
0.16
137
617
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
29
34
9.28
23.13
2.4
2.1
pg
33.4
32.8
0.34
29
34
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
37
59
6.96
22.81
2.3
1.6
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
36
57
6.99
22.33
1.3
1.4
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
117
473
3.33
22.25
3.7
2.5
umol/l
11.6
12.7
0.88
112
432
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
32
45
7.79
22.04
2.1
1.5
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
119
489
3.29
21.99
4.7
2.0
s
31.4
29.7
1.50
113
472
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
28
34
8.93
21.71
2.0
1.9
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
29
37
8.52
21.63
2.3
2.1
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
107
416
3.37
21.61
4.1
2.5
%
24.2
22.4
0.55
97
364
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
33
50
7.25
21.28
2.1
1.7
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
25
27
9.96
21.14
4.2
2.0
e6/l
328.8
708.4
0.88
16
11
(3001122) Ferritin [Mass/volume] in Serum or Plasma
188
1021
3.05
21.05
4.9
2.7
ug/l
222.0
153.4
1.67
180
924
(21494814) CD8 cells/100 lymphocytes in Specimen
27
9
32.60
20.92
1.5
1.7
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
119
508
3.14
20.38
12.3
5.2
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
29
40
7.88
20.27
2.4
2.1
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
22
21
11.18
20.22
2.7
3.0
%
35.3
39.0
—
7
6
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
32
51
6.86
19.67
1.8
1.6
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
30
45
7.25
19.48
2.4
1.6
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
26
33
8.49
19.43
7.6
3.2
%
53.9
57.8
0.28
18
26
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
48
114
4.78
19.33
1.6
2.4
u/l
39.9
38.7
0.11
42
101
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
31
49
6.90
19.20
2.2
1.7
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
160
828
2.87
19.04
11.1
4.5
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
68
214
3.77
18.82
2.8
1.7
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
114
494
3.03
18.78
3.1
2.0
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
25
32
8.39
18.54
2.5
1.9
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
25
32
8.39
18.54
2.5
1.9
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
25
32
8.39
18.54
2.5
1.9
—
—
—
0
0
(3048879) Bone marrow aspiration report
24
9
28.68
18.09
1.3
2.7
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
16
11
15.26
17.74
4.9
1.4
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
30
50
6.52
17.65
2.4
1.6
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
29
48
6.55
17.17
1.8
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
33
63
5.73
16.94
1.8
1.3
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
167
926
2.69
16.77
6.5
3.3
mmol/l
2.3
2.3
0.22
150
813
(3044290) Cell count panel - Cerebral spinal fluid
26
40
6.99
16.46
1.4
1.4
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
22
28
8.37
16.35
1.2
1.2
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
45
116
4.35
16.28
3.2
3.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
26
41
6.82
16.09
9.3
4.4
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
22
29
8.07
15.89
2.6
2.4
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
21
8
27.95
15.80
1.4
1.8
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
28
50
6.04
15.36
1.5
1.3
e6/l
8.4
24.2
0.50
20
37
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
28
50
6.04
15.36
1.6
1.4
e6/l
146.1
2441.0
0.50
20
39
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
17
17
10.51
15.04
2.9
2.1
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
17
17
10.51
15.04
2.9
2.1
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
17
17
10.51
15.04
2.9
2.1
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
17
17
10.51
15.04
2.9
2.1
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
23
35
7.00
14.67
2.4
1.8
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
185
1135
2.50
14.27
25.6
10.2
e9/l
0.0
0.0
0.28
163
937
(3019832) Treponema pallidum Ab [Presence] in Serum
35
82
4.67
14.23
1.4
1.4
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
18
22
8.61
13.76
1.3
1.2
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
23
38
6.45
13.59
1.3
1.2
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
76
312
2.88
13.30
1.4
1.3
titre
220.0
486.3
—
8
70
(3037121) Protein [Mass/volume] in Urine
37
96
4.23
13.21
2.1
3.2
g/l
1.4
0.2
0.56
21
39
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
17
21
8.49
12.87
4.7
1.9
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
115
590
2.48
12.83
1.9
1.7
nmol/l
1161.6
1211.9
0.20
90
452
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
26
52
5.35
12.65
5.7
3.0
%
53.5
59.2
0.95
26
52
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
15
16
9.79
12.64
3.1
2.1
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
15
16
9.79
12.64
3.1
2.1
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
24
45
5.69
12.50
1.9
1.2
u/ml
262.3
331.4
0.28
15
23
(44790047)
21
35
6.35
12.29
2.6
1.8
—
—
—
0
0
(44806118)
21
35
6.35
12.29
2.6
1.8
—
—
—
0
0
(44790049)
21
35
6.35
12.29
2.6
1.8
—
—
—
0
0
(44790048)
21
35
6.35
12.29
2.6
1.8
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
25
50
5.34
12.15
4.6
2.4
e9/l
2.8
4.8
4.71
25
50
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
17
8
22.34
12.14
1.0
1.6
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
15
17
9.21
12.09
3.1
2.1
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
80
355
2.67
11.97
2.7
1.9
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
12
10
12.43
11.80
1.5
1.3
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
258
1935
2.74
11.75
8.1
4.3
mm/h
45.8
13.6
27.06
245
1763
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
80
358
2.65
11.75
2.8
2.0
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
33
86
4.16
11.70
1.8
1.4
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
166
1034
2.26
11.54
4.7
3.6
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
16
21
7.97
11.52
2.1
1.6
—
—
—
0
0
(40758558) Short blood count panel - Blood
120
656
2.33
11.37
21.2
6.7
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
145
859
2.26
11.33
6.3
2.5
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
15
19
8.23
11.10
3.7
4.9
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
183
1201
2.23
11.01
7.9
4.2
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
20
36
5.86
10.84
1.1
1.1
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
88
427
2.47
10.83
2.5
2.0
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
14
17
8.57
10.69
2.3
1.6
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
12
12
10.35
10.50
5.4
1.6
%
96.9
93.5
0.12
12
12
(3033658) Prothrombin time (PT) actual/Normal
120
678
2.23
10.32
9.2
4.4
%
84.1
86.2
0.40
114
670
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
14
18
8.09
10.22
2.3
1.6
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
14
19
7.66
9.78
1.9
1.6
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
28
74
4.05
9.73
1.4
1.4
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
13
17
7.93
9.34
1.0
1.0
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
114
653
2.16
9.30
6.0
2.5
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
53
218
2.72
9.05
4.8
4.1
ng/l
98.0
88.0
0.27
47
195
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
151
971
2.05
8.99
3.8
3.6
ng/l
1811.3
1497.8
0.36
133
840
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
100
560
2.14
8.53
4.9
3.1
mmol/l
2.5
2.5
2.97
90
496
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
12
6
20.70
8.53
1.4
3.8
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
17
33
5.39
8.50
1.8
1.4
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
12
16
7.75
8.47
1.8
1.1
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
126
774
2.04
8.37
4.7
3.5
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
8
0
+∞
8.37
1.5
0.0
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
120
726
2.05
8.30
2.0
1.6
nmol/l
22.3
20.7
0.38
109
609
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
13
9
14.99
8.27
1.1
1.3
—
—
—
0
0
(3024471) HLA-A [Type]
13
9
14.99
8.27
1.0
1.0
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
152
1003
1.98
8.21
5.4
4.2
e6/l
76.8
85.1
0.08
121
736
(3037467) Urinalysis macro (dipstick) panel - Urine
233
1788
2.12
8.17
5.8
4.4
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
138
884
1.99
8.08
4.8
3.6
e6/l
30.8
140.0
0.84
118
690
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
24
65
3.91
8.06
1.6
1.6
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
17
35
5.07
7.98
1.1
1.0
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
14
24
6.06
7.92
2.9
1.5
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
10
12
8.57
7.62
3.8
1.3
—
—
—
0
0
(3024932) HLA-DR beta [Type]
12
9
13.79
7.44
1.1
1.1
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
172
1212
1.91
7.39
11.2
10.1
inr
1.2
1.3
0.42
51
317
(4062490)
14
26
5.59
7.31
1.3
1.2
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
11
7
16.21
7.28
1.3
1.1
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
11
16
7.08
7.19
1.3
1.2
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
165
1156
1.89
7.13
2.6
2.1
pmol/l
93.7
91.2
0.23
106
601
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
29
97
3.19
7.13
2.3
1.2
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
19
48
4.15
6.99
1.1
1.8
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
12
20
6.20
6.95
2.4
1.4
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
12
20
6.20
6.95
1.2
1.1
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
125
807
1.90
6.91
4.8
3.5
e6/l
0.7
0.4
0.47
106
610
(3004451) EKG impression Narrative
11
17
6.67
6.82
1.3
1.3
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
10
6
17.15
6.78
2.9
1.0
%
153.4
130.0
—
10
6
(3000850) Epithelial cells [#/volume] in Urine
102
621
1.94
6.69
3.7
2.7
e6/l
3.2
4.1
0.89
91
548
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
96
573
1.97
6.66
3.2
1.8
mg/l
2.4
1.4
0.53
83
452
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
150
1036
1.85
6.64
3.0
2.3
nmol/l
83.2
78.1
1.00
137
902
(3026008) Bacteria identified in Urine by Culture
126
826
1.87
6.57
3.4
3.4
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
13
26
5.17
6.28
1.2
1.1
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
64
338
2.12
6.17
2.3
1.5
—
—
—
0
0
(3026782) Osmolality of Urine
96
587
1.91
6.14
4.1
3.0
mosm/kgh2o
512.1
565.4
2.15
82
494
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
32
125
2.73
6.00
6.8
3.4
u/ml
0.3
0.4
1.42
15
66
(1616796) Gas panel - Central venous blood
19
54
3.68
5.98
5.0
3.4
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
16
40
4.16
5.97
1.5
1.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
11
20
5.66
5.84
2.5
1.4
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
36
152
2.54
5.80
2.5
2.6
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
15
37
4.20
5.69
1.9
1.3
e6/l
739.9
1777.2
—
10
25
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
19
56
3.54
5.68
1.9
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
19
56
3.54
5.68
1.9
1.4
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
29
111
2.77
5.65
3.6
2.0
—
—
—
0
0
(3000991) Gas panel - Venous blood
52
263
2.17
5.58
15.2
11.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
11
21
5.39
5.56
1.2
1.1
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
17
47
3.76
5.56
2.7
3.0
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
48
237
2.21
5.46
14.0
3.9
mmol/l
1.2
1.2
0.21
48
205
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
8
5
16.35
5.43
1.0
1.0
%
96.5
119.8
—
8
5
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
93
583
1.84
5.42
3.9
4.0
ng/l
1110.8
254.2
0.52
79
497
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
15
39
3.99
5.32
3.2
1.5
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
9
8
11.53
5.32
1.7
1.6
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
11
22
5.14
5.30
1.4
1.1
—
—
—
0
0
(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
5
0
+∞
5.22
1.2
0.0
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
13
31
4.33
5.14
5.2
2.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
65
369
1.96
5.10
1.3
1.2
—
—
—
0
0
(3035880) pH of Pleural fluid
10
19
5.40
5.07
1.0
1.1
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
14
36
4.02
5.04
5.4
4.6
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
22
77
2.99
5.03
1.5
2.5
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
82
505
1.84
5.02
4.0
3.1
e6/l
1.6
1.1
0.30
58
299
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
15
41
3.79
4.98
3.3
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
15
41
3.79
4.98
3.3
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
15
41
3.79
4.98
3.3
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
15
41
3.79
4.98
3.3
1.5
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
12
28
4.41
4.87
1.1
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
12
28
4.41
4.87
1.1
1.1
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
14
37
3.91
4.86
2.4
1.7
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
15
42
3.70
4.82
3.3
1.5
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
59
330
1.97
4.82
2.0
1.7
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
139
1005
1.68
4.81
2.4
2.2
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
8
7
11.68
4.81
6.3
7.3
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
54
293
2.01
4.80
11.7
4.2
mmol/l
2.6
1.8
0.81
44
236
(3000093) Morphology [Interpretation] in Blood Narrative
12
29
4.26
4.67
1.3
1.2
—
—
—
0
0
(3019225) pH of Specimen
50
267
2.03
4.64
10.6
4.1
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
50
268
2.03
4.60
3.0
2.2
g/l
0.2
0.2
4.10
42
246
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
7
5
14.27
4.59
1.6
1.6
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
8
8
10.22
4.54
1.0
1.0
—
—
—
0
0
(3009343) pH of Capillary blood
42
213
2.12
4.47
8.5
4.9
ph
7.4
7.4
—
9
19
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
76
474
1.79
4.42
4.3
3.4
e6/l
1.8
1.6
0.11
52
272
(3017732) Neutrophils [#/volume] in Blood
34
159
2.27
4.40
3.7
2.6
e9/l
3.2
4.1
1.14
21
113
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
16
50
3.32
4.40
5.6
2.9
—
—
—
0
0
(3012565) Volume of 24 hour Urine
9
12
7.68
4.38
4.0
2.8
ml
2234.4
2408.3
—
9
12
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
39
197
2.12
4.19
2.2
1.8
—
—
—
0
0
(4027681)
9
13
7.09
4.19
1.6
1.2
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
20
74
2.82
4.17
2.1
1.5
iu/ml
8.4
0.1
—
6
18
(3003694) ABO and Rh group [Type] in Blood
94
633
1.69
4.15
1.5
1.3
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
55
316
1.89
4.14
2.8
4.0
ug/l
9.3
42.0
0.70
39
269
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
53
301
1.91
4.13
5.5
3.8
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
12
32
3.86
4.12
2.0
1.3
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
8
10
8.17
4.08
1.3
1.0
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
7
7
10.19
4.03
2.4
1.4
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
64
391
1.80
3.96
1.4
1.3
iu/ml
56.6
36.2
0.24
16
126
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
119
861
1.61
3.93
3.9
2.4
u/l
57.8
58.0
0.02
112
796
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
9
15
6.14
3.84
1.6
1.0
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
7
8
8.91
3.79
1.3
1.0
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
45
249
1.94
3.78
3.8
2.6
u/l
26.6
34.6
1.15
37
210
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
6
5
12.19
3.77
1.0
1.0
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
15
50
3.10
3.74
2.9
2.7
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
12
6.80
3.69
1.1
1.1
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
7
9
7.92
3.57
1.4
1.7
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
13
6.28
3.52
1.3
1.1
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
36
189
2.02
3.51
1.9
1.4
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
59
365
1.76
3.49
1.3
1.3
u/ml
0.9
14.4
2.45
17
134
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
16
58
2.85
3.47
1.7
1.3
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
16
58
2.85
3.47
3.9
2.7
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
160
1265
1.53
3.47
4.7
3.9
estimate
0.0
0.0
0.00
34
241
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
146
1135
1.53
3.40
5.6
4.3
ng/l
49.8
43.1
0.20
118
877
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
9
18
5.11
3.39
2.4
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
9
18
5.11
3.39
2.4
1.3
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
9
18
5.11
3.39
1.2
1.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
10
27
3.79
3.38
1.2
1.0
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
7
10
7.13
3.38
1.0
1.3
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
7
10
7.13
3.38
1.7
1.9
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
17
65
2.71
3.36
3.7
2.4
g/l
118.6
126.0
0.39
12
46
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
8
14
5.83
3.36
1.0
1.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
13
43
3.11
3.29
1.2
1.0
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
278
2514
1.82
3.25
47.3
17.0
mg/l
23.7
25.5
0.48
262
2045
(3021601) Nitrite [Presence] in Urine by Test strip
159
1268
1.51
3.23
6.3
5.2
estimate
0.0
0.0
0.00
33
240
(3009261) Glucose [Presence] in Urine by Test strip
161
1288
1.50
3.22
4.7
3.9
estimate
0.0
0.0
0.00
33
229
(3000012) Reticulocyte production index
9
20
4.60
3.13
2.4
2.1
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
9
20
4.60
3.13
1.0
1.0
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
46
274
1.79
3.09
14.2
9.4
mmol/l
1.5
1.4
0.34
46
260
(3013727) Leukocytes other/100 leukocytes in Blood
6
8
7.62
3.06
2.3
8.4
%
42.8
38.8
—
6
8
(3028626) Oxygen [Partial pressure] in Capillary blood
19
83
2.37
2.90
10.4
5.3
kpa
8.7
8.1
0.57
19
75
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
9
6.77
2.88
1.2
1.0
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
6
9
6.77
2.88
1.7
1.4
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
5
6
8.44
2.76
2.0
1.0
%
99.4
66.7
—
5
6
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
5
6
8.44
2.76
1.2
1.3
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
5
6
8.44
2.76
2.0
1.0
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
8
19
4.29
2.69
2.9
1.6
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
16
67
2.46
2.67
3.1
1.5
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
5
7
7.23
2.56
1.2
1.3
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
6
11
5.53
2.55
1.7
1.2
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
40
244
1.73
2.49
2.6
1.9
nmol/l
329.1
384.1
1.06
40
221
(3037692) Legionella sp identified in Specimen by Organism specific culture
7
16
4.45
2.49
1.3
1.3
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
36
214
1.77
2.45
1.6
1.8
%
1.7
1.7
0.09
29
181
(3009542) Hematocrit [Volume Fraction] of Blood
242
2161
1.50
2.45
44.1
18.8
%
34.9
39.1
6.38
156
1424
(3016650) Hepatitis A virus Ab [Presence] in Serum
11
40
2.81
2.40
1.0
1.1
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
54
363
1.59
2.33
10.8
8.8
mmol/l
1.1
1.2
0.08
43
285
(3000492) Spirometry study
36
218
1.73
2.31
1.5
1.6
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
6
13
4.68
2.28
11.2
4.5
u/l
177.2
231.8
—
6
13
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
5
9
5.62
2.22
18.2
7.8
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
5
9
5.62
2.22
17.8
7.8
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
109
855
1.42
2.22
2.1
2.1
u/l
97.2
231.6
4.95
102
801
(3052851) Hemolysis interference index of Serum or Plasma
18
87
2.13
2.21
3.5
3.7
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
20
101
2.05
2.21
2.9
1.7
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
35
214
1.71
2.18
2.5
2.9
ml/min/173m2
44.6
61.7
1.97
16
91
(3002523) Influenza virus A Ag [Presence] in Specimen
7
19
3.74
2.16
1.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
7
19
3.74
2.16
1.0
1.1
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
179
1537
1.38
2.09
6.0
3.3
u/l
59.8
56.2
0.21
164
1415
(3011397) Hemoglobin [Presence] in Urine by Test strip
80
599
1.45
2.08
4.8
3.8
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
5
10
5.06
2.08
7.0
4.7
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
5
10
5.06
2.08
1.0
1.0
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
5
10
5.06
2.08
4.0
7.8
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
24
134
1.86
2.01
1.7
1.3
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
7
21
3.38
1.97
1.7
1.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
28
166
1.75
1.95
10.0
5.1
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
5
11
4.60
1.95
4.0
1.6
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
6
16
3.80
1.94
1.7
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
6
16
3.80
1.94
1.7
1.2
—
—
—
0
0
(3019060) Gas panel - Arterial blood
34
216
1.64
1.86
6.0
4.3
—
—
—
0
0
(3013005) Retinol [Moles/volume] in Serum or Plasma
5
12
4.21
1.83
3.2
1.5
umol/l
2.5
1.5
—
5
12
(40761536) Microorganisms panel - Urine sediment
34
219
1.62
1.77
6.0
3.9
—
—
—
0
0
(40768441) Liver Pathology biopsy report
6
19
3.20
1.67
2.0
1.0
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
7
25
2.84
1.66
1.1
1.4
—
—
—
0
0
(3002256) Pathology report gross observation
47
332
1.49
1.64
1.4
1.3
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
40
273
1.53
1.64
2.4
2.8
ug/l
15.9
7.4
0.38
34
239
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
147
1258
1.31
1.61
3.2
2.4
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
13
64
2.08
1.56
1.9
1.6
—
—
—
0
0
(40761535) Cells panel - Urine sediment
36
243
1.54
1.56
4.7
3.5
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
7
27
2.63
1.52
1.1
1.4
nmol/l
0.6
0.5
—
7
22
(3024891) Influenza virus A+B Ag [Presence] in Specimen
12
59
2.07
1.45
1.3
1.3
—
—
—
0
0
(3013512) EKG study
102
841
1.31
1.44
5.1
4.4
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
205
1853
1.30
1.42
3.9
3.7
pmol/l
14.7
15.0
1.09
180
1635
(3048689) Calprotectin [Mass/mass] in Stool
35
240
1.51
1.42
1.7
2.2
ug/g
189.2
151.4
0.23
25
194
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
26
167
1.61
1.39
15.3
13.2
mmol/l
24.3
24.5
0.14
26
155
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
116
980
1.29
1.35
5.1
4.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
6
24
2.53
1.31
1.0
1.4
nmol/l
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
6
24
2.53
1.31
1.2
1.0
ng/l
854.3
548.1
—
6
13
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
6
24
2.53
1.31
1.2
1.0
ng/l
272.8
256.7
—
6
12
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
6
24
2.53
1.31
1.2
1.0
ng/l
34.7
39.2
—
6
11
(3051611) Lipemic interference index of Serum or Plasma
8
36
2.25
1.25
2.3
3.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
14
79
1.81
1.19
1.7
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
14
79
1.81
1.19
1.7
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
14
79
1.81
1.19
1.7
1.2
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
11
57
1.96
1.18
1.3
1.2
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
23
151
1.56
1.15
4.2
3.4
mmol/l
25.2
24.8
0.19
23
146
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
15
88
1.74
1.13
1.7
1.6
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
7
140
0.49
1.12
2.0
1.8
—
—
—
0
0
(3022621) pH of Urine by Test strip
27
186
1.49
1.10
3.3
3.0
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
7
32
2.21
1.08
1.9
1.3
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
278
2657
1.36
1.05
47.5
20.3
umol/l
92.6
83.2
1.44
278
2657
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
24
164
1.50
1.02
14.8
12.6
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
7
35
2.02
1.00
1.0
1.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
82
688
1.26
0.99
4.1
3.6
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
5
23
2.19
0.98
1.0
1.3
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
7
36
1.97
0.97
2.6
2.6
nmol/l
2.8
8.2
—
7
36
(3040151) Glucose [Moles/volume] in Capillary blood
7
36
1.97
0.97
3.1
8.3
mmol/l
6.3
6.3
—
7
30
(3051651) Icteric interference index of Serum or Plasma
6
27
2.24
0.94
2.3
3.2
—
—
—
0
0
(4268621)
6
27
2.24
0.94
1.8
2.0
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
6
27
2.24
0.94
1.7
1.3
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
52
415
1.30
0.93
30.3
26.0
inr
1.1
1.3
—
8
51
(3004716) Salmonella sp identified in Stool by Organism specific culture
17
110
1.58
0.92
1.7
1.3
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
228
2411
0.81
0.92
5.9
6.5
mmol/mol
39.5
40.9
1.79
207
2217
(21494755) Public health laboratory ask at order entry panel
7
127
0.54
0.90
1.4
1.5
—
—
—
0
0
(4306422)
6
30
2.02
0.87
1.0
1.3
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
56
679
0.79
0.86
1.9
1.7
mmol/l
1.3
1.3
0.01
50
558
(3022145) Colonoscopy Study observation
38
293
1.34
0.86
1.3
1.3
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
138
1240
1.20
0.85
4.5
5.3
ug/l
1.7
2.8
2.16
119
1108
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
8
45
1.80
0.85
1.4
1.2
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
73
617
1.24
0.83
1.6
1.8
pmol/l
464.8
444.1
0.25
58
506
(3012516) Albumin [Mass/volume] in Urine
97
848
1.21
0.79
5.7
3.3
mg/l
9903.6
203.4
5.19
79
561
(1761482) Bacteria [#/volume] in Urine by Culture
14
90
1.58
0.79
3.2
4.7
—
—
—
0
0
(3020891) Body temperature
18
124
1.48
0.77
5.1
4.4
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
20
141
1.45
0.76
1.8
3.1
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
7
39
1.81
0.73
2.4
1.8
%
90.2
89.2
—
7
39
(1761868) Lipid panel - Serum or Plasma
67
781
0.82
0.73
3.0
3.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
18
126
1.45
0.72
1.2
1.3
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
5
27
1.86
0.68
1.2
2.3
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
268
2583
1.23
0.68
35.2
15.8
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
5
95
0.52
0.67
1.0
1.6
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
7
43
1.64
0.67
1.3
1.1
u/l
9.8
8.1
—
7
35
(3011648) Oxygen content in Venous blood
5
28
1.80
0.66
31.4
3.8
%
7.7
11.3
—
5
28
(3044889) 12 lead EKG panel
198
1863
1.17
0.64
5.7
4.4
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
5
29
1.74
0.64
1.0
1.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
20
148
1.37
0.61
3.4
3.8
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
8
51
1.58
0.61
1.1
1.5
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
8
54
1.49
0.57
2.6
2.4
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
57
491
1.20
0.55
1.4
1.2
u/ml
0.5
1.1
—
8
125
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
6
38
1.59
0.54
2.2
1.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
26
205
1.29
0.54
1.1
1.4
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
21
161
1.33
0.53
1.2
1.2
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
79
708
1.15
0.48
5.9
4.2
estimate
0.0
0.0
0.00
29
233
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
238
2461
0.87
0.47
4.3
4.8
mmol/l
4.1
4.5
4.43
216
2235
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
238
2295
1.15
0.46
4.6
4.5
mu/l
2.0
2.0
0.08
217
2044
(3024928) Oxygen saturation in Venous blood
11
77
1.44
0.46
23.9
3.3
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
237
2445
0.88
0.42
4.3
4.8
mmol/l
1.4
1.4
1.19
213
2205
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
8
58
1.39
0.42
1.1
1.1
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
8
60
1.34
0.40
1.0
1.2
—
17.2
—
0
6
(3007461) Platelets [#/volume] in Blood
279
2732
1.17
0.37
64.5
24.7
e9/l
233.5
239.7
0.61
274
2663
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
8
115
0.69
0.37
1.6
1.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
19
234
0.80
0.37
1.6
1.5
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
246
2526
0.89
0.37
4.7
5.5
mmol/l
2.3
2.6
6.28
223
2278
(3010813) Leukocytes [#/volume] in Blood
279
2733
1.17
0.37
64.6
24.7
e9/l
6.7
6.9
0.35
272
2655
(3026361) Erythrocytes [#/volume] in Blood
279
2733
1.17
0.37
64.5
24.7
e12/l
4.0
4.5
29.84
272
2653
(3044941) Cell count panel - Synovial fluid
6
41
1.47
0.36
1.0
1.5
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
62
559
1.14
0.36
5.3
4.3
kg/l
1.0
1.0
—
10
86
(4094501)
5
79
0.63
0.36
1.0
1.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
13
100
1.31
0.34
2.3
1.9
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
243
2365
1.12
0.33
36.9
16.0
ml/min/173m2
74.1
74.7
0.16
219
1975
(3033705) Calcium.ionized [Moles/volume] in Venous blood
6
46
1.31
0.33
4.3
2.8
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
7
54
1.30
0.30
1.1
1.3
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
105
987
1.10
0.29
3.9
4.7
%
21.1
21.4
0.06
51
499
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
38
341
1.13
0.25
17.0
8.3
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
9
77
1.17
0.24
1.3
1.3
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
232
2371
0.92
0.24
4.1
4.3
mmol/l
1.2
1.3
1.13
206
2124
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
5
41
1.22
0.22
1.8
1.6
ug/l
34.0
17.0
—
5
41
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
0
11
0.00
0.21
0.0
1.8
—
62.0
—
0
11
(3006598) pH of Arterial cord blood
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3021706) Oxygen [Partial pressure] in Arterial cord blood
0
10
0.00
0.21
0.0
1.0
—
4.0
—
0
10
(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood
0
10
0.00
0.21
0.0
1.0
—
5.8
—
0
10
(3044007) Cell count panel - Peritoneal fluid
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
0
12
0.00
0.21
0.0
1.2
—
377.0
—
0
6
(3037556) Urate [Mass/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.5
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
94
899
1.06
0.17
4.0
4.1
mg/mmol
17.3
8.7
0.67
63
581
(3003338) MCHC [Mass/volume]
205
2009
1.06
0.16
57.0
22.8
g/l
329.1
332.0
4.01
205
2000
(3017446) Testosterone [Moles/volume] in Serum or Plasma
24
218
1.11
0.14
1.9
2.2
nmol/l
11.9
12.7
0.21
24
192
(3039443) Prostate specific Ag panel - Serum or Plasma
5
61
0.82
0.08
1.6
1.8
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
89
867
1.04
0.08
3.4
3.2
mmol/l
6.7
7.3
0.71
77
708
(4010399)
22
205
1.08
0.08
1.4
1.5
—
—
—
0
0
(1002224) Polysomnography panel
8
90
0.89
0.07
1.3
1.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
9
103
0.87
0.06
1.0
1.0
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
12
109
1.10
0.06
1.0
1.2
iu/ml
26.0
146.4
—
5
38
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
73
713
1.03
0.05
2.9
3.1
ug/l
0.7
0.8
0.66
50
497
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
29
296
0.98
0.00
1.3
1.4
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
35
356
0.98
0.00
4.4
4.7
%
31.6
31.2
0.07
25
231
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
248
2482
1.00
0.00
5.0
5.1
mmol/l
6.0
6.1
0.85
218
2239
(3013139) Helicobacter pylori Ag [Presence] in Stool
14
144
0.97
0.00
1.3
1.2
—
—
—
0
0
(3008898) HLA-B27 [Presence]
5
53
0.94
0.00
1.2
1.2
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
7
75
0.93
0.00
2.0
1.7
nmol/l
35.3
45.6
—
7
70
(40768800) Prostate Pathology biopsy report
8
84
0.95
0.00
1.4
1.1
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
7
0.00
0.00
0.0
6.4
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
6
61
0.98
0.00
32.8
2.7
%
56.4
66.2
—
6
61
(3022689) Creatine [Moles/volume] in Urine
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
7.6
—
1401.1
—
0
8
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.3
—
85.9
—
0
8
(3027901) Hemoglobin [Mass/volume] in Arterial cord blood
0
8
0.00
0.00
0.0
1.0
—
150.5
—
0
8
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.2
—
0.8
—
0
5
(3020650) Glucose [Presence] in Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
3.5
—
96.5
—
0
6
(3000285) Sodium [Moles/volume] in Blood
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
5.4
—
980.9
—
0
8
(3036071) Salmonella sp Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_IMMUNOPROLIFERATIVE – Malignant immunoproliferative diseases
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).